
Internal Reference Number: FOI_9065
Date Request Received: 26/11/2025 00:00:00
Date Request Replied To: 09/12/2025 00:00:00
This response was sent via: By Email
Request Summary: HAE & IG questionnaire
Request Category: Companies
| Question Number 1: I am writing to request the following information under the FOIA. If you require any clarification regarding this request, please do not hesitate to contact me. HAE & IG questionnaire HAE: In the past 3 months [latest 3 months available] how many patients have received the following treatments [for any disease]: Berinert (Human C1-esterase inhibitor) Cinryze (Human C1-esterase inhibitor) Orladeyo (Berotralstat) Takhzyro (Lanadelumab) Ruconest (Recombinant human C1-esterase inhibitor) Firazyr (Icatibant injection) Icatibant - any brand except Firazyr | |
| Answer To Question 1: Please see our response to all questions in the Excel spreadsheet attached. To accompany this answer to question 1 please also see the documents listed below: | |
| Question Number 2: IG: In the past 3 months how many patients have received the following treatment for any disease: Octagam Gamunex Intratect Kiovig Gamten Panzyga Xembify Cuvitru Cutaquig Hyqvia | |
| Answer To Question 2: Please see our response to all questions in the Excel spreadsheet attached. | |
| Question Number 3: In the past 3 months, how many patients have received any immunoglobulin treatment for the following diseases: Primary immunodeficiency (PID) Secondary immunodeficiency (SID) Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) | |
| Answer To Question 3: Please see our response to all questions in the Excel spreadsheet attached. | |
| Please see Attachments: | |
| To return to the list of all the FOI requests please click here | |
Our staff at SA¹ú¼Ê´«Ã½ Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.